HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Solutions Cellu-Sculpt Marketed As Slimming Treatment

This article was originally published in The Rose Sheet

Executive Summary

Avon Solutions Cellu-Sculpt is debuting in April as an anti-cellulite slimming product that treats the condition by targeting firmness, dimpling and texture, the direct-seller said

You may also be interested in...



Avon Cellu-Sculpt 60% Cellulite Reduction Claim Discontinued On NAD Review

Avon has discontinued a claim used in print and broadcast ads for its Cellu-Sculpt Anti-Cellulite Slimming Treatment stating, "Visibly reduce cellulite by up to 60%. Improve firmness by over 60%." The company has decided to omit the statement from advertising following a review by the National Advertising Division of the Council for Better Business Bureaus

Avon Cellu-Sculpt 60% Cellulite Reduction Claim Discontinued On NAD Review

Avon has discontinued a claim used in print and broadcast ads for its Cellu-Sculpt Anti-Cellulite Slimming Treatment stating, "Visibly reduce cellulite by up to 60%. Improve firmness by over 60%." The company has decided to omit the statement from advertising following a review by the National Advertising Division of the Council for Better Business Bureaus

Avon Planet Spa Launch Blasts Off

Avon is launching Planet Spa as an extension of its Wellness brand featuring two new product ranges, White Tea for the face and South Pacific for the body, the direct-seller said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010911

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel